z-logo
open-access-imgOpen Access
High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer
Author(s) -
Aziz Zaanan,
Claire Calmel,
Julie Henriques,
Magali Svrcek,
Hélène Blons,
Christèle DesboisMouthon,
Fatiha Merabtene,
Claire Goumard,
Yann Parc,
Brice Gayet,
Julien Taı̈eb,
Pierre Validire,
Christophe Louvet,
Jean–François Fléjou,
Yves Le Bouc,
Françoise Praz
Publication year - 2019
Publication title -
cellular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.698
H-Index - 40
eISSN - 2211-3436
pISSN - 2211-3428
DOI - 10.1007/s13402-019-00484-6
Subject(s) - insulin like growth factor 1 receptor , medicine , immunohistochemistry , proportional hazards model , stage (stratigraphy) , colorectal cancer , oncology , cancer , protein expression , receptor , gastroenterology , pathology , growth factor , biology , gene , paleontology , biochemistry
The aim of this study was to investigate the association between expression of insulin-like growth factor-1 receptor (IGF1R) and its ligand, IGF-II, and disease-free survival (DFS) in patients with stage III colon cancer (CC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom